Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B3 | P37058 | 1/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | ALPL | P05186 | 5/20 | 0.52 |
| ▸ | ALPI | P09923 | 4/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 7/20 | 0.48 |
| ▸ | MAOA | P21397 | 5/20 | 0.48 |
| ▸ | NQO1 | P15559 | 1/20 | 0.48 |
| ▸ | NT5E | P21589 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30876199 | 1.00 | HSD17B3 (0.60) | HSD17B3KDM4EMEN1CYP3A4MAPT | |
| SCHEMBL29206959 | 0.87 | HSD17B3 (0.73) | HSD17B3KDM4EMEN1CYP3A4MAPT | |
| SCHEMBL3076160 | 0.84 | HSD17B3 (0.57) | HSD17B3KDM4EMEN1CYP3A4MAPT | |
| SCHEMBL3079524 | 0.84 | HSD17B3 (0.57) | HSD17B3KDM4EMEN1CYP3A4MAPT | |
| SCHEMBL3078189 | 0.84 | HSD17B3 (0.57) | HSD17B3KDM4EMEN1CYP3A4MAPT | |
| SCHEMBL4570872 | 0.81 | NQO1 (0.57) | HSD17B3KDM4EMEN1CYP3A4MAPT | |
| SCHEMBL11067092 | 0.80 | KDM4E (0.66) | HSD17B3KDM4EMEN1CYP3A4MAPT | |
| SCHEMBL3086227 | 0.77 | HSD17B3 (0.60) | HSD17B3KDM4EMEN1CYP3A4MAPT | |
| SCHEMBL1091352 | 0.76 | HSD17B3 (0.55) | HSD17B3KDM4EMEN1CYP3A4MAPT | |
| SCHEMBL1133508 | 0.75 | HSD17B3 (1.00) | HSD17B3ALPLALPIMAOBMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118005591-A | Coumarin derivative and synthetic method and application thereof | 陕西科技大学 | 2024-05-10 | — | — | CN | disclosed |
| CN-118005599-A | 7-Aminocoumarin derivative and synthetic method and application thereof | 陕西科技大学 | 2024-05-10 | — | — | CN | disclosed |
| US-10329542-B2 | HBV RNAse H purification and enzyme inhibitors | SAINT LOUIS UNIVERSITY (US) | 2019-06-25 | — | — | US | disclosed |
| US-20170335296-A1 | HBV RNASE H PURIFICATION AND ENZYME INHIBITORS | SAINT LOUIS UNIVERSITY (US) | 2017-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170335296-A1 | HBV RNASE H PURIFICATION AND ENZYME INHIBITORS | RNASEH1, RNASE1, RNASEL | HSD17B3 2020/4885KDM4E 3174/4885MEN1 2978/4885 |
| US-10329542-B2 | HBV RNAse H purification and enzyme inhibitors | RNASEH1, RNASE1, RNASEL | HSD17B3 2020/4885KDM4E 3174/4885MEN1 2978/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.